Connection

Chitra Lal to Muscarinic Antagonists

Back to Details
This is a "connection" page, showing publications Chitra Lal has written about Muscarinic Antagonists.
Chitra Lal
Connection Strength
2.265
Muscarinic Antagonists
  1. Emerging Treatments for COPD: Evidence to Date on Revefenacin. COPD. 2020 02; 17(1):112-119.
    View in: PubMed
    Score: 0.667
  2. A review of current and developing fixed-dose LABA/LAMA combinations for treating COPD. Expert Opin Pharmacother. 2017 Dec; 18(17):1833-1843.
    View in: PubMed
    Score: 0.578
  3. Spotlight on fluticasone furoate/umeclidinium/vilanterol in COPD: design, development, and potential place in therapy. Int J Chron Obstruct Pulmon Dis. 2017; 12:135-140.
    View in: PubMed
    Score: 0.544
  4. Aclidinium bromide plus formoterol for the treatment of chronic obstructive pulmonary disease. Expert Opin Pharmacother. 2015 Feb; 16(3):427-34.
    View in: PubMed
    Score: 0.476
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.